Phosphodiesterase 4 inhibitors and the treatment of asthma: where are we now and where do we go from here?

Abstract excerpt

Research conducted over the last 20 years has established that inflammation of the airways is central to the airway dysfunction that characterises asthma. Typically, the airway wall is infiltrated by a variety of cells including mast cells, eosinophils and T lymphocytes, which have deviated towards a T(H)2 phenotype. Together, these cells release a plethora of mediators including interleukin (IL)-4, IL-5,...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to 3',5'-Cyclic-AMP Phosphodiesterases
• Share to Asthma
• Share to Biological Availability